Abstract:INTRODUCTION: Mitochondrial fatty acid β-oxidation defects (FAODs) are a group of severe inherited metabolic diseases, most of which can be treated with favorable prognosis following diagnosis. A description of the broad range of phenotypes resulting from these defects remains incomplete, and for this study, we sought to investigate the semiology at diagnosis in a country without a newborn screening program for FAODs.METHODS: Using a retrospective French multicentre study, we analyzed 187 children aged <6 years at diagnosis with FAOD confirmed by enzymatic and/or molecular analyses. Clinical and biological parameters at diagnosis were assessed to screen liver, heart, neurological, and muscle symptoms. Information concerning the long-term prognosis was also collected.RESULTS: Predominant hepatic symptoms were observed in 89 % of patients regardless of the underlying defect. The most frequent symptoms observed were hepatomegaly (92 %), increased blood alanine aminotransferase (ALAT) level (82 %), and steatosis (88 %). Other frequent features included Reye syndrome (49 %), increased gamma-glutamyltranspeptidase (GGT) (37 %), and liver failure (27 %). Extrahepatic features were often associated in the foreground. Hypoglycemia (75 %), neurological (64 %), muscle (61 %), or cardiac features (55 %) [as either cardiomyopathy (47 %) or arrhythmias (31 %)] were frequently documented. Hemodynamic events (41 %) were represented by shock (31 %) or sudden death (35 %). Hyperammonemia (73 %) and hyperlactacidemia (57 %) were the two main biochemical features. Total, very-long-chain acyl-CoA dehydrogenase (VLCADD), long-chain 3-hydroxyacylCoA dehydrogenase (LCHADD), and medium-chain acyl-CoA dehydrogenase (MCADD) deficiency mortality rates were 48 %, 60 %, 63 %, and 20 % respectively.CONCLUSION: This study presents clinical features of a large cohort of patients with FAODs in a country without neonatal screening for FAODs. Our results highlight liver as the main organ involved at diagnosis regardless of age at diagnosis, classical phenotype (i.e., cardiac, hepatic, or muscular), or enzyme deficiency. Although steatosis may be observed in various inherited metabolic defects, it is a reliable indicator of FAOD and should prompt systematic screening when the diagnosis is suspected. The poor long-term prognoses reported are a strong argument for inclusion of FAODs in newborn screening programs.

Characterization of 42 Egyptian Children with Lysosomal Storage Disorders

Demographic Characteristics and Distribution of Lysosomal Storage Disorder Subtypes in Eastern China

Oral health status of Egyptian children with lysosomal storage diseases: An evaluation of dental indices, salivary cytokines level, and bacterial bioburden

Disease Spectrum Analysis of 1 520 Cases with Lysosomal Storage Disorders

Neurological manifestations in Pakistani lysosomal storage disorders patients and molecular characterization of Gaucher disease

An Approach to the Diagnosis of Lysosomal Storage Diseases

Identification of Five Novel Mutations Causing Rare Lysosomal Storage Diseases

Expanding the genotypic and phenotypic spectrum of Egyptian children with maple syrup urine disease

The Liver and Lysosomal Storage Diseases: From Pathophysiology to Clinical Presentation, Diagnostics, and Treatment

Enzymatic Screening and Diagnosis of Lysosomal Storage Diseases

Lysosomal diseases: biochemical pathways and investigations

Fetal Phenotyping and Whole Exome Sequencing for 12 Egyptian Families With Serine Biosynthesis Defect: Novel Clinical and Allelic Findings With a Founder Effect

Evaluation of Lysosphingolipid Analysis for the Diagnosis of Lysosomal Storage Disease

Sphingolipidoses of Lysosomal Storage Disorders

[Lysosomal storage disorders - Fabry disease and Gaucher disease]

Genetic blueprint of congenital muscular dystrophies with brain malformations in Egypt: A report of 11 families

Clinical, Pathological and Molecular Genetic Analysis of Pediatric Lipid Storage Myopathy

Clinical and biological features at diagnosis in mitochondrial fatty acid beta-oxidation defects: a French pediatric study of 187 patients

L-2-hydroxyglutaric aciduria: a report of clinical, radiological, and genetic characteristics of two siblings from Egypt

Evidence of epigenetic landscape shifts in mucopolysaccharidosis IIIB and IVA

Clinical Phenotypes and Immunological Characteristics of 18 Egyptian LRBA Deficiency Patients